News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
278 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18005)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (249)
2 (227)
3 (175)
4 (72)
5 (2)
6 (9)
7 (175)
8 (219)
9 (161)
10 (259)
11 (113)
12 (7)
13 (2)
14 (172)
15 (304)
16 (260)
17 (238)
18 (120)
19 (1)
20 (3)
21 (214)
22 (269)
23 (243)
24 (278)
25 (118)
26 (3)
27 (18)
28 (238)
29 (307)
30 (277)
31 (323)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Biotech Beach
BIOLASE Announces Pricing of $8.5 Million Public Offering of Common Stock and Concurrent Private Placement of Convertible Preferred Stock
BIOLASE has granted the underwriters a 30-day over-allotment option to purchase up to an additional 1,173,000 shares of common stock at the public offering price, less the underwriting discount.
October 24, 2019
·
6 min read
Business
Centers for Medicare and Medicaid Services Makes It Easier for Healthcare Providers to Choose Axolotl Biologix Products to Spur Wound and Tissue Regeneration
Axolotl’s DualGraft™ and Axolotl Graft™ products have been assigned the code Q4210.
October 24, 2019
·
1 min read
Job Trends
PDL BioPharma Responds to Letter from Engine Capital
Harold E. Selick, Ph.D., Chairman of the Board of Directors of PDL BioPharma, has sent the following letter to Engine Capital, LP.
October 24, 2019
·
2 min read
Genetown
Fujifilm Debuts Eight New State-Of-The-Art Endoscopes At ACG 2019
Company to support multiple educational opportunities for clinicians during conference
October 24, 2019
·
6 min read
Genetown
Attention Doggie Lowriders - Find Out If Your Dog Is At Genetic Risk For A Slipped Disc
Embark adds screening for intervertebral disc disease to its 170+ Genetic Health Disease Tests
October 24, 2019
·
3 min read
LivaNova to Present at the Stifel 2019 Healthcare Conference
The discussion will be available to all interested parties through a live audiocast accessible via the Investor Relations section of the LivaNova website at www.livanova.com.
October 24, 2019
·
2 min read
Deals
CEL-SCI Corporation Issues Letter to Shareholders - Oct. 24, 2019
We at CEL-SCI have been believers in the value of immunotherapy for treating cancer for decades before others recognized it’s potential.
October 24, 2019
·
11 min read
Pharm Country
Advaxis Announces Business and Pipeline Update
Cash balance anticipated to extend into 2021
October 24, 2019
·
8 min read
Business
Harvard Business Review Names CSL’s Paul Perreault Among Best Performing CEOs in the World
Top 100 CEO rankings based on financial performance as well as environmental, social, and governance (ESG) ratings
October 24, 2019
·
4 min read
Business
Beroni Group to Launch its Advanced US FDA-Approved Virus Diagnostic Kit to Help Combat Global Outbreaks of Zika, Dengue, Chikungunya and West Nile Viruses
It was developed by Professor W. Ian Lipkin of Columbia University who is internationally recognized as an authority on the use of molecular methods for pathogen discovery and was the first to use purely molecular methods to identify an infectious agent and a pioneer in the use of high throughput sequencing in pathogen discovery.
October 24, 2019
·
5 min read
Previous
24 of 28
Next